FDA Investigator John R Myung

John R Myung has inspections in 2 countries as of 30 Nov 2023. John R Myung has collaborated with a combinined 4629 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
235
Last Inspection Date:
30 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100006059
Country:
United States of America, Brazil
Co-Investigator(s):
Ademola O Daramola, Adriana Meza, Albert C Cheng, Alexandra B Pitkin, Ali Hernandez, Amalia C Himaya, Amalia Himaya, Ana Djurdjevic, Ana M Pietsch, Anderson, Andrew K Haack, PhD, Andrew S Johnson, Andy B Lee, Angela Shepas, Anita Narula, PhD, Anthony E Guzman, Avery J Dennis, Barry Cherney, PhD, Benigno B Devera, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonnie I Needleman, Bowman, Brandon R Boone, Brian Ravitch, Brien C Fox, Bruce W Benware, Burnsb, Bush, Carla J Lundi, Carol S Sanchez, Carr Sharpe, Caryn M Mcnab, Cathryn M Groehnert, Celena Ngo, Cheron M Portee, Christina V Santos, Christopher M Elliott, Comyar Shoghi, Corey A Cruse, Cristina E Graves, Cristina E Mosquera, Crystal Monroy, Daniel J Simonsen, Daniel W Cline, Darrin E Davis, David A Quale, David G Whitman, David Serrano, Davinna Ligons, PhD, Davis, Debbie K Giang, Deborah A Greco, Deborah L Parker, Deborah W Hsu, Debra D Devlieger, Debra J Fracassa, Deidre R Edwards, Dejon N Harris, Dennis N Hoang, Desiree C Iya, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Eileen T Dupont, Elizabeth M Dahl, Elizabeth Q Maccorkell, Ellen N Stewart, Elodie Xtong Lin, Erica Aspinwall Brown, Erik D Sandvig, Erika V Butler, Fe Q Reyes, Frances Namuswe, PhD, Francisco, Gabriel Craig, Gale L Glinecki, Garciam, Gene D Arcy, Geoffrey M Leist, Geraldine M Peregrin, Glenn R Archambault, Glorioso M Pama, Gordon Chu, Greg K Keshishyan, Guillermo, Gulshan R Anand, Gunneet Kaur, Hagstrom, Hai T Truong, Haley H Seymour, Haley Seymour, Harmon M Blanch, Haroon Vohra (NMI), Hasan A Irier, PhD, Henry E Carrillo, Herminio C Francisco, Hoover, Ian J Thomson, Iris C Macinnes, Ivar J Sohn, James A Barreto, James E Bentson, James P Stallings, James R Fleckenstein, Janice Wai, Jeanne A Young, Jeanne M Weishaar, Jeannie Pradyanata, Jee Chung, PhD, Jeff M Uriarte, Jeffrey P Raimondi, Jennifer Gogley, Jennifer L Johnson, Jennifer M Gogley, Jennifer Wcheng Dobson, Jessica L Andrade, Jhakeim D Seaberry, Jimmy C Ngan, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel Welch, PhD, John A Liu, John C Su, John E Emmert, John P Jorgensen, Jonathan R Ormond, Jonathan T Little, Jose O Caraballo Rivera, Joseph A Seitz, Joseph C Francisco, Joseph C Yen, Joseph H Lam, Joseph M Allen, Juanita Banuelos, Judy C Nepsa, Jun Park, PhD, Justin M Runac, Ka L Wong, Kai Wang, Karla J Gibler, Katherine P Chan, Katherine P Tran, Kathleen R Jones, PhD, Katie T Duong, Kawshalya Pathiraja, Keeshunna D Daniels, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin Lee, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Khang K Pham, Khoa Nathanv Tran, Kim Lthomas Cruse, Kimberly M Lichter, Lanita F Kelley, Laura Fontan, MS, LCDR Wilfred A Darang, Leonard H Lavi, Leongc, Lesley A Swanson, Lilly O Barton, Liming Zhang, Lin Liu, Lisa M Schultz, Lourdes M Countee, Marcel G Belen, Marcia Britt Williams, Marco A Solorio, Marcus F Yambot, Mario A Iglesias, Mark E Moen, Mark Gray, Matthew C Kristof, Maurice M Sheehan, Maxyne Lam, Maxyne T Lam, Mcgrewp, Melody M Ragasa Leong, Michael D Garcia, Michael F Schuette, Michael S Call, Michelle A Marsh, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Nianna C Burns, Nicholas J Lahey, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Ounchith J Phabmixay, Patrick R Dimapindan, Patti A Walters, Peter S Diak, Phal K Chhun, Phillip J Sample, Phillip L Toy, Quyen T Tien, Rachel C Stanton, Randal Anderson, Randall J Plunkett, Raphelia Spisso, Rebecca I Campalans, Rebecca L Stephany, Rebecca Rodriguez, Richard W Tubb, Richmond K Yip, Robert C Hoover, Robert D Ogan, Robert D Tollefsen, Robert Darius, Rocco C Black, Rochelle A Rolnik, Rocio Guzman Velazquez, Roger F Zabinski, Romero, Ronald L Koller, Ronda Lebland, Rowena S Nguyen, Ryan J Borges, Sandersk, Sandra I Gaul, Sara H Gabel, Sara Jdent Acosta, Sarah A Hassas, Sarah Arden, Scott R Nichols, PhD, Selene T Torres, Sherry G Gonzalez, Sidney B Priesmeyer, Sonia R Peterson, Sonya L Karsik, Sparky L Bartee, Stanley Au, State Agency, Stephen G Mclane, Steven Fong, MS, PhD, Stuart W Russell, Susan I Shaffer, Sylvia A Thomas, Taichun Qin, PhD, Tamara L Alexander, Tanya E Malais, Terrance P Nguyen, Terri L Dodds, Terry L Boles, Thanh B Tran, Thanh M Andrews, Thao T Kwan, Thao Tran, Thao X Tran, Theresa Kirkham (NMI), Thomas C Mclean, CFS, Tom Limchumroom, Tracey T Duong, Trushani T Desai, Uttaniti Limchumroon (Tom), William J Leonard, Wr Bowman, Yasamin Ameri, Yolanda D Mitchell Lee, Yumi J Hiramine, Yvette E Guillermo, Yvonne C Wilkes, Yvonne M Larsen, Yvonne T Lacour

John R Myung's Documents

Publish Date Document Type Title
December, 2011 EIR Neutraderm, Inc. - EIR, 2011-12-02
May, 2011 EIR Amgen, Inc - EIR, 2011-05-20
December, 2011 FDA 483 Neutraderm, Inc. - Form 483, 2011-12-02
May, 2011 FDA 483 Cardinal Health 414, LLC - Form 483, 2011-05-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more